Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C. (Q39984667)

16 September 2017

title

Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C. (English)

1 reference

16 September 2017

main subject

hepatocellular carcinoma

1 reference

Hla-Hla Thein

2

0 references

Heather F Gidding

object named as

Heather F Gidding

3

0 references

Janaki Amin

object named as

Janaki Amin

4

0 references

Gregory J Dore

7

object named as

Gregory J Dore

1 reference

16 September 2017

Scott R Walter

1

1 reference

16 September 2017

Matthew G Law

5

1 reference

16 September 2017

Jacob George

6

1 reference

16 September 2017

publication date

1 December 2011

1 reference

Journal of Gastroenterology and Hepatology

16 September 2017

published in

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

12

1 reference

16 September 2017

page(s)

1757-1764

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Global cancer statistics in the year 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Hepatitis B and C viruses in the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Natural history of hepatitis-related hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Epidemiological characteristics and risk factors of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Epidemiology and natural history of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Chronic viral hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Chronic hepatitis B and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Estimates of chronic hepatitis B virus infection in Australia, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Randomized controlled trial of screening for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

Therapeutic advances in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06785.X

10.1111/J.1440-1746.2011.06785.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference